HealthCor Management’s Quest Diagnostics DGX Stock Holding History

HealthCor Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-735,930	Closed	-$79.4M	–	42
2018 Q3	$79.4M	Sell	735,930 -261,650	-26%	-$28.7M	2.63%	17
2018 Q2	$110M	Buy	+997,580	New	+$104M	3.48%	9
2017 Q2	–	Sell	-78,982	Closed	-$7.75M	–	43
2017 Q1	$7.75M	Sell	78,982 -1,046,018	-93%	-$99.7M	0.36%	35
2016 Q4	$103M	Buy	1,125,000 +966,220	+609%	+$83.3M	5.84%	5
2016 Q3	$13.4M	Sell	158,780 -991,220	-86%	-$83.2M	0.82%	27
2016 Q2	$93.6M	Sell	1,150,000 -700,000	-38%	-$53.3M	5.11%	7
2016 Q1	$132M	Buy	1,850,000 +1,325,350	+253%	+$88.9M	7.49%	2
2015 Q4	$37.3M	Buy	+524,650	New	+$35.3M	2.27%	19

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HealthCor Management's DGX Position: Q4 2018 in Review

HealthCor Management sold out of Quest Diagnostics (DGX) in Q4 2018, closing a stake of 735,930 shares — an estimated $79.4M sold.

HealthCor Management first reported a position in DGX in Q4 2015 and held it in 8 quarters. The position peaked at $132M in Q1 2016. 624 funds tracked by Wall St. Rank hold DGX as of Q4 2018.

HealthCor Management reported no remaining Quest Diagnostics position as of Q4 2018 after selling out during the quarter.
HealthCor Management sold 735,930 Quest Diagnostics shares in Q4 2018, an estimated $79.4M.
HealthCor Management first reported a position in Quest Diagnostics in Q4 2015 and held it in 8 quarters.
HealthCor Management's Quest Diagnostics position peaked at $132M in Q1 2016.
624 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2018.

Based on HealthCor Management's 13F filing for Q4 2018, filed 14 Feb 2019.